Inactivation of human immunodeficiency virus type 1 (HIV-1) and mutagenicity testing in human platelet concentrates (PC) after treatment with a coumarin-based compound and long wavelength ultraviolet A light (UVA)

被引：0
|
作者：
SowemimoCoker, SO [1 ]
Park, S [1 ]
Yerram, NR [1 ]
Crandall, S [1 ]
Goodrich, RP [1 ]
机构：
[1] CRYOPHARM CORP,PASADENA,CA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3433 / 3433
页数：1
相关论文
共 50 条
  • [1] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) IN HUMAN PLATELET CONCENTRATES USING (PC) A NOVEL PSORALEN DERIVATIVE (CP-38) AND LONG-WAVELENGTH ULTRAVIOLET-A LIGHT (UVA)
    GOODRICH, RP
    SOWEMIMOCOKER, SO
    ANTHONY, RP
    YERRAM, NR
    PARK, S
    GOODRICH, T
    CRANDALL, S
    FORSTER, P
    JONES, D
    PLATZ, M
    [J]. TRANSFUSION, 1994, 34 (10) : S42 - S42
  • [2] INACTIVATION OF BLOOD-BORNE PATHOGENS AND MUTAGENICITY TESTING IN HUMAN PLATELET CONCENTRATES (PC) USING NOVEL PHOTO-SENSITIZERS AND LONG-WAVELENGTH ULTRAVIOLET A LIGHT (UVA)
    SOWEMINOCOKER, SO
    GOODRICH, RP
    ANTHONY, RP
    YERRAM, NR
    PARK, S
    GOODRICH, BT
    CRANDALL, S
    FORSTER, P
    JONES, D
    PLATZ, MS
    [J]. BLOOD, 1994, 84 (10) : A465 - A465
  • [3] INACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY ULTRAVIOLET AND X-IRRADIATION
    HENDERSON, EE
    TUDOR, G
    YANG, JY
    [J]. RADIATION RESEARCH, 1992, 131 (02) : 169 - 176
  • [4] IN-VITRO PROPERTIES OF HUMAN PLATELET CONCENTRATES FOLLOWING 6 LOG HIV-1 VIRUS INACTIVATION CONDITIONS USING PSORALEN DERIVATIVE (CP-38) AND ULTRAVIOLET-A (UVA) LIGHT
    YERRAM, NR
    SWEMIMOCOKER, SO
    PARK, SC
    GOODRICH, BT
    CRANDALL, S
    GOODRICH, RP
    [J]. BLOOD, 1994, 84 (10) : A673 - A673
  • [5] Inactivation and purification of human immunodeficiency virus-1 as antigen for the treatment of HIV-1 infection
    Prior, CP
    Gore, R
    Harter, J
    Berbaum, M
    Duffy, C
    Ferre, F
    Hancock, R
    Lowry, P
    Musil, R
    Stiglitz, M
    Carlo, DJ
    Richieri, SP
    Maigetter, RZ
    [J]. BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1996, 9 (09): : 22 - &
  • [6] Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection
    Miró, JM
    Sued, O
    Plana, M
    Pumarola, T
    Gallart, T
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (10): : 643 - 659
  • [7] Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1)
    Belanger, Julie M.
    Raviv, Yossef
    Viard, Mathias
    de la Cruz, M. Jason
    Nagashima, Kunio
    Blumenthal, Robert
    [J]. VIROLOGY, 2011, 417 (01) : 221 - 228
  • [8] Mechanisms of human immunodeficiency virus type 1 (HIV-1) neutralization: Irreversible inactivation of infectivity by anti-HIV-1 antibody
    McDougal, JS
    Kennedy, MS
    Orloff, SL
    Nicholson, JKA
    Spira, TJ
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (08) : 5236 - 5245
  • [9] Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection
    Enting, RH
    Prins, JM
    Jurriaans, S
    Brinkman, K
    Portegies, P
    Lange, JMA
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) : 1095 - 1099
  • [10] Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen
    Moss, RB
    Wallace, MR
    Giermakowska, WK
    Webb, E
    Savary, J
    Chamberlin-Brandt, C
    Theofan, G
    Musil, R
    Richieri, SP
    Jensen, FC
    Carlo, DJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 641 - 648
12345